Clinical Trial Update: Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 2/Phase 3 pilot clinical trial evaluating 3,4-diaminopyridine for botulism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Botulism

Drugs mentioned

• 3,4-Diaminopyridine (3,4-diaminopyridine)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Botulism | Phase 2, Phase 3 | Status: COMPLETED